PharmAust (ASX:PAA) Total Stockholders Equity : A$7.46 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PharmAust Total Stockholders Equity?

PharmAust's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$7.46 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PharmAust's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PharmAust's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

PharmAust Total Stockholders Equity Historical Data

The historical data trend for PharmAust's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmAust Total Stockholders Equity Chart

PharmAust Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

7.46

8.53

8.88

7.84

3.89

PharmAust Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															8.42	7.84	7.73	3.89	7.46

PharmAust (ASX:PAA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PharmAust's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7.463	-	0)	/	374.066
	=	0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PharmAust's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	7.463
	=	0.00

PharmAust Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PharmAust's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmAust (ASX:PAA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmAust Ltd (ASX:PAA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ECQ:Germany ECQ:Germany

Address

1 Kyle Way, Suite 116, Claremont, Perth, WA, AUS, 6010

Website

https://www.pharmaust.com

PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.